Clinical Outcomes of Antiplatelets Combined with Statins in Patients with Ischemic Heart Disease-Reference-Cited by-同舟云学术

Clinical Outcomes of Antiplatelets Combined with Statins in Patients with Ischemic Heart Disease

Published:2019-12-31 Issue:4 Volume:29 Page:254-266
ISSN:1226-6051
Container-title:Korean Journal of Clinical Pharmacy
language:en
Short-container-title:Korean J Clin Pharm

Author:

Kim Chungsoo¹,Lee Jimin²,Park Rae Woong¹³,Lee Sukhyang²

Affiliation:

1. Department of Biomedical Science, Graduate School of Medicine, Ajou University, Suwon 16499, Republic of Korea

2. College of Pharmacy, Ajou University, Suwon 16499, Republic of Korea

3. Department of Biomedical Informatics, School of Medicine, Ajou University, Suwon 16499, Republic of Korea

Publisher

The Korean College of Clinical Pharmacy

Subject

General Medicine

Link

http://pdf.medrang.co.kr/KJCP/2019/029/KJCP029-04-05.pdf

Reference29 articles.

1. Health Insurance Review Assessment Service. Healthcare Bigdata hub. Available from <uri>http://opendata.hira.or.kr/op/opc/olapHifrqSickInfo.do</uri> Accessed August 12 2019

2. 2018 American Heart Association/American College of Cardiology Multisociety Guideline on the Management of Blood Cholesterol

3. 2018 American Heart Association/American College of Cardiology/Multisociety Guideline on the Management of Blood Cholesterol–Secondary Prevention

4. Antiplatelet Drugs

5. 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetic and Safety Comparison of Fixed‐Dose Combination of Cilostazol/Rosuvastatin (200 + 20 mg) Versus Concurrent Administration of the Separate Components in Healthy Adults;Clinical Pharmacology in Drug Development;2024-03-12

2. Vasodilator agents improve hemodialysis vascular access patency;Medicine;2021-10-08